跳至主要内容
临床试验/NL-OMON34770
NL-OMON34770尚未招募4 期

CO-trimoxazole PRophylaxis for recurrent respiratory INfections in ChildrEn (the CO-PRINCE study) - The CO-PRINCE study.

Jeroen Bosch Ziekenhuis0 个研究点目标入组 170 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
170

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • Children >6 months and <18 years with recurrent respiratory infections visiting pediatricians and ENT-surgeons in participating hospitals will be included if informed consent is obtained from the parents, and children (if >11 years). Definition of 'recurrent' respiratory infections: >=3 respiratory infections in the 6 months preceding study entry or start of the current therapy, or >=4 per year (documented by a doctor and treated with antibiotics).

排除标准

  • - known primary immunodeficiency (e.g. CVID, a/hypogammaglobulinemia);
  • - known secondary immunodeficiency (e.g. HIV, chemotherapy, transplantation);
  • - eponymous syndromes;
  • - chromosomal abnormalities;
  • - cleft palate;
  • - renal or hepatic insufficiency;
  • - known glucose-6-phosphate deficiency, cystic fibrosis, primary ciliary dyskinesia or acute porphyria;
  • - children using drugs known to interact with co-trimoxazole;
  • - children with previous allergic reaction to co-trimoxazole.

研究者

发起方
Jeroen Bosch Ziekenhuis

相似试验